menu search

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to tumor-infiltrating lymphocyte (TIL) therapy, today announced the pricing of its upsized initial public offering of 6,666,667 shares of common […] The post Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering appeared fi... Read More
Posted: Jul 21 2023, 06:15
Author Name: forextv
Views: 102028

Search within

Pages Search Results: